Jörgen Mölgaard

The effect of probucol on femoral atherosclerosis: The Probucol Quantitative Regression Swedish Trial (PQRST)

Göran Walldius, Uno Erikson, Anders Olsson et al. · The American Journal of Cardiology · 1994 · 250 citations

Medicine, Cardiology, Preventive Medicine +11

Lowering of HDL _2b by Probucol Partly Explains the Failure of the Drug to Affect Femoral Atherosclerosis in Subjects With Hypercholesterolemia

Jan Johansson, Anders Olsson, L. Bergstrand et al. · Arteriosclerosis Thrombosis and Vascular Biology · 1995 · 81 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Development of femoral atherosclerosis in hypercholesterolemic patients during treatment with cholestyramine and probucol/placebo: Probucol quantitative regression Swedish trial (PQRST): A status report

Göran Walldius, Lars A. Carlson, Uno Erikson et al. · The American Journal of Cardiology · 1988 · 61 citations

Pharmacy, Cardiology, Pharmacotherapy +16

Alfalfa seeds lower low density lipoprotein cholesterol and apolipoprotein B concentrations in patients with type II hyperlipoproteinemia

Jörgen Mölgaard, H. von Schenck, Anders Olsson · Atherosclerosis · 1987 · 50 citations

Agriculture, Nutrition, Nutritional Sciences +13

Long-term efficacy and safety of simvastatin alone and in combination therapy in treatment of hypercholesterolaemia

Jörgen Mölgaard, Björn L. Lundh, H. von Schenck et al. · Atherosclerosis · 1991 · 39 citations

Pharmacy, Pharmacology, Pharmacotherapy +13